REG - Citadel Group Sanofi SA - Form 8.3 - Horizon Therapeutics PLC
02/12/2022 15:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221202:nRSB4832Ia&default-theme=true
RNS Number : 4832I Citadel Group 02 December 2022
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Citadel Group
Company dealt in HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note Common Stock ISIN IE00BQPVQZ61
2)
Date of dealing 01 December, 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security
dealt in (Note 3)
Long Short
ISIN IE00BQPVQZ61 Number (%) Number (%)
(1) Relevant securities 2,772,282 (1.22%) 178,337 (0.07%)
(2) Derivatives (other than options) 0 (0.00%) 77,000 (0.03%)
(3) Options and agreements to purchase/sell 357,111 (0.15%) 178,843 (0.07%)
Total 3,129,393 (1.38%) 434,180 (0.19%)
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
ISIN IE00BQPVQZ61
Buy Transaction 32,438 100.8900 USD
Buy Transaction 7,399 100.8900 USD
Buy Transaction 10,965 101.3766 USD
Buy Transaction 5,000 102.2016 USD
Buy Transaction 3,620 101.4944 USD
Buy Transaction 35 101.4944 USD
Buy Transaction 1 100.8900 USD
Buy Transaction 1,179 101.4967 USD
Buy Transaction 250 101.3920 USD
Buy Transaction 121 101.1769 USD
Buy Transaction 104 100.9481 USD
Buy Transaction 1 102.4000 USD
Sell Transaction 140 101.0296 USD
Sell Transaction 257 101.0929 USD
Sell Transaction 347 103.1631 USD
Sell Transaction 200 102.7400 USD
Sell Transaction 300 103.0400 USD
Sell Transaction 600 102.5817 USD
Sell Transaction 1 101.0296 USD
Sell Transaction 20 100.8800 USD
Sell Transaction 96 100.8800 USD
Sell Transaction 100 102.5000 USD
Sell Transaction 134 100.8101 USD
Sell Transaction 697 102.5202 USD
Sell Transaction 802 100.8800 USD
Sell Transaction 2,790 102.2116 USD
Sell Transaction 3,486 100.8800 USD
Sell Transaction 3,932 102.0576 USD
Sell Transaction 4,325 100.8800 USD
Sell Transaction 5,036 101.8533 USD
Sell Transaction 6,059 102.2075 USD
Sell Transaction 7,506 102.5270 USD
Sell Transaction 13,844 102.2055 USD
Sell Transaction 29,387 102.3400 USD
Sell Transaction 3,253 103.1631 USD
Sell Transaction 2 101.0296 USD
DVP Transaction 1 100.8900 USD
DVP Transaction 7,399 100.8900 USD
DVP Transaction 32,438 100.8900 USD
RVP Transaction 32,438 100.8900 USD
RVP Transaction 7,400 100.8900 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
ISIN IE00BQPVQZ61
(c) Options transactions in respect of existing relevant
securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option Writing, selling, purchasing, Number of securities to which the option relates (Note 7) Exercise price Type, Expiry date Option money paid/ received per unit
varying etc. e.g. American, European etc. (Note 5)
Call Option Buy Transaction 1,500 120.0000 DOL.C-USAA Amer Opt 20/01/2023 3.4500 USD
Call Option Buy Transaction 3 115.0000 DOL.C-USAA Amer Opt 17/02/2023 6.0000 USD
Call Option Buy Transaction 3 115.0000 DOL.C-USAA Amer Opt 17/02/2023 6.1400 USD
Call Option Sell Transaction 3,000 130.0000 DOL.C-USAA Amer Opt 20/01/2023 0.9750 USD
Call Option Sell Transaction 6 125.0000 DOL.C-USAA Amer Opt 17/02/2023 2.3000 USD
Call Option Sell Transaction 6 125.0000 DOL.C-USAA Amer Opt 17/02/2023 2.3700 USD
(ii) Exercising
Product name, Number of securities Exercise price per unit
e.g. call option (Note 5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Name of person dealing (Note 1) Citadel Group
Company dealt in HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note Common Stock ISIN IE00BQPVQZ61
2)
Date of dealing 01 December, 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security
dealt in (Note 3)
Long Short
ISIN IE00BQPVQZ61 Number (%) Number (%)
(1) Relevant securities 2,772,282 (1.22%) 178,337 (0.07%)
(2) Derivatives (other than options) 0 (0.00%) 77,000 (0.03%)
(3) Options and agreements to purchase/sell 357,111 (0.15%) 178,843 (0.07%)
Total 3,129,393 (1.38%) 434,180 (0.19%)
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
ISIN IE00BQPVQZ61
Buy Transaction 32,438 100.8900 USD
Buy Transaction 7,399 100.8900 USD
Buy Transaction 10,965 101.3766 USD
Buy Transaction 5,000 102.2016 USD
Buy Transaction 3,620 101.4944 USD
Buy Transaction 35 101.4944 USD
Buy Transaction 1 100.8900 USD
Buy Transaction 1,179 101.4967 USD
Buy Transaction 250 101.3920 USD
Buy Transaction 121 101.1769 USD
Buy Transaction 104 100.9481 USD
Buy Transaction 1 102.4000 USD
Sell Transaction 140 101.0296 USD
Sell Transaction 257 101.0929 USD
Sell Transaction 347 103.1631 USD
Sell Transaction 200 102.7400 USD
Sell Transaction 300 103.0400 USD
Sell Transaction 600 102.5817 USD
Sell Transaction 1 101.0296 USD
Sell Transaction 20 100.8800 USD
Sell Transaction 96 100.8800 USD
Sell Transaction 100 102.5000 USD
Sell Transaction 134 100.8101 USD
Sell Transaction 697 102.5202 USD
Sell Transaction 802 100.8800 USD
Sell Transaction 2,790 102.2116 USD
Sell Transaction 3,486 100.8800 USD
Sell Transaction 3,932 102.0576 USD
Sell Transaction 4,325 100.8800 USD
Sell Transaction 5,036 101.8533 USD
Sell Transaction 6,059 102.2075 USD
Sell Transaction 7,506 102.5270 USD
Sell Transaction 13,844 102.2055 USD
Sell Transaction 29,387 102.3400 USD
Sell Transaction 3,253 103.1631 USD
Sell Transaction 2 101.0296 USD
DVP Transaction 1 100.8900 USD
DVP Transaction 7,399 100.8900 USD
DVP Transaction 32,438 100.8900 USD
RVP Transaction 32,438 100.8900 USD
RVP Transaction 7,400 100.8900 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
ISIN IE00BQPVQZ61
(c) Options transactions in respect of existing relevant
securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option Writing, selling, purchasing, Number of securities to which the option relates (Note 7) Exercise price Type, Expiry date Option money paid/ received per unit
varying etc. e.g. American, European etc. (Note 5)
Call Option Buy Transaction 1,500 120.0000 DOL.C-USAA Amer Opt 20/01/2023 3.4500 USD
Call Option Buy Transaction 3 115.0000 DOL.C-USAA Amer Opt 17/02/2023 6.0000 USD
Call Option Buy Transaction 3 115.0000 DOL.C-USAA Amer Opt 17/02/2023 6.1400 USD
Call Option Sell Transaction 3,000 130.0000 DOL.C-USAA Amer Opt 20/01/2023 0.9750 USD
Call Option Sell Transaction 6 125.0000 DOL.C-USAA Amer Opt 17/02/2023 2.3000 USD
Call Option Sell Transaction 6 125.0000 DOL.C-USAA Amer Opt 17/02/2023 2.3700 USD
(ii) Exercising
Product name, Number of securities Exercise price per unit
e.g. call option (Note 5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure: 02 December, 2022
Contact name: Paula Sharp
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated
None
Is a Supplemental Form 8 attached? (Note 9)
NO
Date of disclosure: 02 December, 2022
Contact name: Paula Sharp
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ISEEADAAESEAFFARecent news on Sanofi SA
See all newsREG - Deutsche Bank AG FF - Pre Stabilisation Notice - Sanofi 2yr FRN & 6y FXD
AnnouncementREG - Stock Exch Notice - Admission to ISM - 14/02/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 17/09/2024
AnnouncementREG - Stock Exch Notice - Admission to ISM - 17/06/2024
AnnouncementRCS - Issuer Direct NEWCO - Ad Scientiam Launches Study to Assess MSCopilot
Announcement